Search all trials

Find therapies in clinical trials near you – page 61

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 961
countries: 28
conditions: 2 103

3 961 trials recruiting28 European countries2 103 conditions coveredUpdated today

Quick filters

Study on the Safety and Tolerability of Imdusiran and Durvalumab for Patients with Chronic Hepatitis B

Not recruiting

Registered drugNo placebo

Study on the Safety and Tolerability of Imdusiran and Durvalumab for Patients with Chronic Hepatitis B

Registered drugNo placebo

Poland

Participants:18–64 years
Substances:Ab-729

Contact Research Centre

Non-small cell lung cancer

Not recruiting

Registered drugNo placebo

Study on the Effectiveness and Safety of Alectinib, Entrectinib, and a Drug Combination for Patients with Advanced or Metastatic Non-Small Cell Lung Cancer

Registered drugNo placebo

Poland

Participants:18–64 years · 65+ years

Contact Research Centre

Paroxysmal nocturnal haemoglobinuria

Not recruiting

Registered drugNo placebo

Study Comparing Crovalimab and Eculizumab for Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH) Currently on Complement Inhibitors

Registered drugNo placebo

Poland

Participants:0–17 years · 18–64 years · 65+ years
Substances:Crovalimab

Contact Research Centre

Non-small cell lung cancer

Not recruiting

Registered drugNo placebo

Study on Continued Ceritinib Treatment for Patients with ALK Positive Non-Small Cell Lung Cancer

Registered drugNo placebo

Poland

Participants:0–17 years · 18–64 years · 65+ years
Substances:Ceritinib

Contact Research Centre

Eosinophilic granulomatosis with polyangiitis

Not recruiting

Registered drug

Study on the Effectiveness and Safety of Depemokimab vs. Mepolizumab for Adults with Relapsing or Refractory Eosinophilic Granulomatosis with Polyangiitis

Registered drug

Poland

Participants:18–64 years · 65+ years
Substances:Depemokimab

Contact Research Centre

Hidradenitis

Not recruiting

Investigational

Study of Eltrekibart for Adults with Moderate to Severe Hidradenitis Suppurativa

Investigational

Poland

Participants:18–64 years · 65+ years
Substances:Humanised Igg4 Kappa Monoclonal Antibody Against Cxcl1, Cxcl2, Cxcl3, Cxcl5, Cxcl6, Cxcl7 And Cxcl8

Contact Research Centre

Clear cell papillary renal cell carcinoma

Not recruiting

Registered drugNo placebo

Study Comparing Savolitinib and Durvalumab with Sunitinib and Durvalumab for Patients with Advanced Papillary Renal Cell Carcinoma

Registered drugNo placebo

Poland

Participants:18–64 years · 65+ years
Substances:Durvalumab

Contact Research Centre

Non-small cell lung cancer+2

Not recruiting

Registered drugNo placebo

Study Comparing Lorlatinib and Crizotinib for Patients with Advanced ALK-Positive Non-Small Cell Lung Cancer

Registered drugNo placebo

Poland

Participants:18–64 years
Substances:Lorlatinib

Contact Research Centre

Hormone receptor positive HER2 negative breast cancer

Not recruiting

Registered drugNo placebo

Study Comparing Datopotamab Deruxtecan to Chemotherapy in Patients with Advanced Hormone Receptor-Positive, HER2-Negative Breast Cancer

Registered drugNo placebo

Poland

Participants:18–64 years · 65+ years
Substances:Capecitabine

Contact Research Centre

Study on the Effects of NMRA-335140 for Adults with Major Depressive Disorder

Not recruiting

Investigational

Study on the Effects of NMRA-335140 for Adults with Major Depressive Disorder

Investigational

Poland

Participants:18–64 years
Substances:1-[6-Ethyl-8-Fluoro-4-Methyl-3-(3-Methyl-1,2,4-Oxadiazol-5-Yl)Quinolin-2-Yl]-N-(Oxan-4-Yl)Piperidin-4-Amine

Contact Research Centre

Hormone-dependent prostate cancer

Not recruiting

Registered drug

Study of Capivasertib and Abiraterone for Patients with Metastatic Hormone-Sensitive Prostate Cancer with PTEN Deficiency

Registered drug

Poland

Participants:18–64 years · 65+ years
Substances:Abiraterone Acetate

Contact Research Centre

Non-small cell lung cancer

Not recruiting

Registered drugNo placebo

Study of datopotamab deruxtecan combined with immunotherapy and carboplatin in patients with advanced or metastatic non-small cell lung cancer

Registered drugNo placebo

Poland

Participants:18–64 years · 65+ years
Substances:Carboplatin

Contact Research Centre

Find therapies in clinical trials near you – page 61

864 trials match your criteria

Study on the Safety and Tolerability of Imdusiran and Durvalumab for Patients with Chronic Hepatitis B

Study on the Safety and Tolerability of Imdusiran and Durvalumab for Patients with Chronic Hepatitis B

Non-small cell lung cancer

Study on the Effectiveness and Safety of Alectinib, Entrectinib, and a Drug Combination for Patients with Advanced or Metastatic Non-Small Cell Lung Cancer

Paroxysmal nocturnal haemoglobinuria

Study Comparing Crovalimab and Eculizumab for Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH) Currently on Complement Inhibitors

Non-small cell lung cancer

Study on Continued Ceritinib Treatment for Patients with ALK Positive Non-Small Cell Lung Cancer

Eosinophilic granulomatosis with polyangiitis

Study on the Effectiveness and Safety of Depemokimab vs. Mepolizumab for Adults with Relapsing or Refractory Eosinophilic Granulomatosis with Polyangiitis

Hidradenitis

Study of Eltrekibart for Adults with Moderate to Severe Hidradenitis Suppurativa

Clear cell papillary renal cell carcinoma

Study Comparing Savolitinib and Durvalumab with Sunitinib and Durvalumab for Patients with Advanced Papillary Renal Cell Carcinoma

Non-small cell lung cancer+2

Study Comparing Lorlatinib and Crizotinib for Patients with Advanced ALK-Positive Non-Small Cell Lung Cancer

Hormone receptor positive HER2 negative breast cancer

Study Comparing Datopotamab Deruxtecan to Chemotherapy in Patients with Advanced Hormone Receptor-Positive, HER2-Negative Breast Cancer

Study on the Effects of NMRA-335140 for Adults with Major Depressive Disorder

Study on the Effects of NMRA-335140 for Adults with Major Depressive Disorder

Hormone-dependent prostate cancer

Study of Capivasertib and Abiraterone for Patients with Metastatic Hormone-Sensitive Prostate Cancer with PTEN Deficiency

Non-small cell lung cancer

Study of datopotamab deruxtecan combined with immunotherapy and carboplatin in patients with advanced or metastatic non-small cell lung cancer

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.